These U.S. and Canadian companies are scheduled to report their quarterly earnings for the fiscal 2014 today. Below is a preview of their key earning metrics, based on consensus estimates of analysts polled by Bloomberg. We have also provided analysts’ consensus buy ratings for these stocks with upside/downside potential for the upcoming 12-months.
| Company | Ticker | Exchange | Market Cap (MM) |
Last Price | Industry | Reporting Time |
Quarter | Sales ($MM) (Growth) |
Net Income ($MM) (Growth) |
EPS ($) (Growth) |
Total Analyst Coverage |
Buy Rating | Upside Potential |
| Acuity Brands Inc | AYI | NYSE | 5,086.8 | 117.71 | Lighting Products&Sys | BMO | Q4’14 | 649.39 (12.0%) |
53.01 (18.1%) |
1.22 (18.4%) |
14 | 57% | 21% |
| AZZ Inc | AZZ | NYSE | 1,071.4 | 41.77 | Diversified Manufact Op | BMO | Q2’15 | 203.00 (23.7%) |
16.60 (3.1%) |
0.66 (3.2%) |
6 | 67% | 28% |
| Fabrinet | FN | NYSE | 512.6 | 14.60 | Diversified Manufact Op | NA | Q4’14 | 172.00 (7.5%) |
11.23 (-25.8%) |
0.33 (-24.4%) |
7 | 57% | 23% |
| Xencor Inc | XNCR | NASDAQ | 292.3 | 9.31 | Therapeutics | NA | Q3’14 | 1.34 (NA) |
-4.96 (NA) |
-0.16 (NA) |
5 | 80% | 75% |
| InspireMD Inc | NSPR | NYSE | 77.4 | 2.20 | Medical Products | NA | Q4’14 | 0.00 (-100.0%) |
-6.20 (58.5%) |
-0.17 (64.6%) |
4 | 100% | 178% |
| Synergetics USA Inc | SURG | NASDAQ | 86.4 | 3.41 | Medical Instruments | NA | Q4’14 | 17.70 (-0.9%) |
0.65 (-54.8%) |
0.03 (-50.0%) |
4 | 100% | 105% |
| IntelliPharmaCeutics International Inc/CA | I | TSX | 79.1 | 3.39 | Drug Delivery Systems | NA | Q3’14 | 1.39 (NA) |
-3.29 (-60.6%) |
-0.14 (-40.0%) |
4 | 100% | 177% |
Source: Bloomberg
Note: Sales, Net Income & EPS are Bloomberg estimated figures and the growth rates mentioned are year-over-year.
AMC: After Market Close
BMO: Before Market Open
NA: Not Available
NM: Not Meaningful
